Prelude Therapeutics, Inc. (PRLD)
3.855
-0.04
(-0.90%)
USD |
NASDAQ |
Oct 12, 10:56
Prelude Therapeutics Net Income (Quarterly) : -13.92M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.92M |
| March 31, 2026 | -10.38M |
| December 31, 2025 | -16.46M |
| September 30, 2025 | -19.72M |
| June 30, 2025 | -31.23M |
| March 31, 2025 | -32.08M |
| December 31, 2024 | -28.73M |
| September 30, 2024 | -32.27M |
| June 30, 2024 | -34.74M |
| March 31, 2024 | -31.43M |
| December 31, 2023 | -33.08M |
| September 30, 2023 | -30.61M |
| June 30, 2023 | -30.43M |
| March 31, 2023 | -27.72M |
| Date | Value |
|---|---|
| December 31, 2022 | -28.64M |
| September 30, 2022 | -29.96M |
| June 30, 2022 | -27.37M |
| March 31, 2022 | -29.46M |
| December 31, 2021 | -32.84M |
| September 30, 2021 | -30.69M |
| June 30, 2021 | -26.86M |
| March 31, 2021 | -21.30M |
| December 31, 2020 | -19.25M |
| September 30, 2020 | -16.76M |
| June 30, 2020 | -11.41M |
| March 31, 2020 | -9.511M |
| December 31, 2019 | -10.04M |
| September 30, 2019 | -6.734M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Q32 Bio, Inc. | -8.946M |
| Intellia Therapeutics, Inc. | -106.63M |
| Twist Bioscience Corp. | -35.05M |
| Beam Therapeutics, Inc. | -122.68M |
| Revolution Medicines, Inc. | -644.37M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.704M |
| Total Expenses (Quarterly) | 19.62M |
| EPS Diluted (Quarterly) | -0.1415 |
| Enterprise Value | 176.15M |
| Gross Profit Margin (Quarterly) | 93.81% |
| Profit Margin (Quarterly) | -244.1% |
| Earnings Yield | -20.44% |
| Normalized Earnings Yield | -20.44 |